skip to content

Interim Results

BTG has strong first half

15 November 2016 07:52

BTG reports a strong first half performance with double-digit revenue growth.

Revenues rose to £285.4m in the six months to the end of September - 24% up on a year ago and 10% higher at constant currencies. Revenues from interventional medicine increased to£98.1m from £70.5m - up 39% and 24% at constant currencies.

Adjusted operating profit rose to £78.8m from £62.9m.

Chief executive Louise Makin said: "The business has performed well during the first half, and the outlook for the full year is strong. We have the capabilities and financial strength to take advantage of the increasing opportunities we are seeing to expand our Interventional Medicine business. By accelerating our growth strategy through reinvestment of our cash flows to maximise the value of and expand the current portfolio, we can build leadership positions in selected areas of interventional medicine and thereby create sustainable value for shareholders."

Story provided by StockMarketWire.com

Related Company: BTG

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

-

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.